Revised guidelines for Australian laboratories performing mycobacteriology testing. 2020

Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
SA Pathology, PO Box 14, Rundle Mall, Adelaide SA 5000.

Mycobacteriology laboratories play a key role in tuberculosis (TB) control by providing phenotypic and molecular diagnostics, by performing molecular typing to aid contact tracing, and by supporting research and similar laboratories in Australia's neighbouring countries where TB is prevalent. The National Tuberculosis Advisory Committee (NTAC) published a set of laboratory guidelines in 2006 aiming to document the infrastructure, equipment, staffing and work practices required for safe high-quality work in Australian mycobacteriology laboratories. These revised guidelines have the same aims and have been through a similar extensive consultative peer-review process involving the Mycobacterium Reference Laboratory (MRL) network, the Mycobacterium Special Interest Group (SIG) of the Australian Society for Microbiology (ASM), and other relevant national bodies. This revised document contains several significant changes reflecting the publication of new biosafety guidelines and tuberculosis standards by various national and international organisations, technology developments - such as the MPT64-based immunochromatographic tests (ICTs) and the Xpert MTB/RIF assay, and updated work practices in mycobacteriology laboratories. The biosafety recommendations affirm the latest Australian/New Zealand Standard 2243.3: 2010 and promote a biorisk assessment approach that, in addition to the risk categorisation of the organism, also considers the characteristics of the procedure being performed. Using this biorisk assessment approach, limited manipulations, such as Ziehl-Neelsen (ZN) microscopy, MPT64 ICTs, and culture inactivation/DNA extraction for molecular testing, may be performed on a positive TB culture in a PC2 laboratory with additional features and work practices. Other significant changes include recommendations on the integration of MPT64 ICTs and novel molecular tests into TB laboratory workflows to provide rapid accurate results that improve the care of TB patients. This revised document supersedes the original 2006 publication. NTAC will periodically review these guidelines and provide updates as new laboratory technologies become available.

UI MeSH Term Description Entries
D007753 Laboratories Facilities equipped to carry out investigative procedures. Laboratory
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001315 Australia The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra. Canton and Enderbury Islands,Christmas Island,Christmas Island (Australia)
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice

Related Publications

Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
January 2006, Communicable diseases intelligence quarterly report,
Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
December 2004, Fertility and sterility,
Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
November 2008, Fertility and sterility,
Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
November 2006, Fertility and sterility,
Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
June 2008, Human reproduction (Oxford, England),
Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
April 2016, Human reproduction (Oxford, England),
Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
March 2003, Journal of clinical microbiology,
Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
November 2001, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports,
Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
November 2018, The Medical journal of Australia,
Ivan Bastian, and Lisa Shephard, and Richard Lumb, and
May 2007, The Clinical biochemist. Reviews,
Copied contents to your clipboard!